<p>PetMed Express, Inc.（纳斯达克代码：PETS - 获取免费报告）在 12 月份的空头头寸大幅增加。截至 12 月 15 日，空头头寸总计为 2,698,921 股，比 11 月 30 日的 1,604,421 股增加了 68.2%。根据平均每日交易量 12,363,353 股，目前的空头头寸比率为 0.2 天。大约 12.9% 的股票被做空。</p>
<p>获取 <strong>PetMed Express</strong> 警报：</p>
<h2>PetMed Express 股价下跌 2.3%</h2>
<ul>
<li>Petco Health &amp; Wellness 是否因每股收益超预期而摆脱困境？</li>
</ul>
<p>在周五的交易时段，PetMed Express 股票下跌了 0.08 美元，报 3.47 美元。该公司交易了 108,088 股，较其平均交易量 7,696,855 股有所减少。该股票的市值为 7415 万美元，市盈率为-1.31，贝塔值为 0.75。该公司的 50 日移动平均线为 2.46 美元，200 日移动平均线为 2.86 美元。PetMed Express 的 1 年最低价为 1.57 美元，1 年最高价为 5.58 美元。</p>
<p>PetMed Express（纳斯达克代码：PETS - 获取免费报告）最后一次公布季度财报是在 12 月 19 日（星期五）。该公司报告季度每股收益为（0.41 美元），低于市场共识预期的 0.04 美元，差距为（0.45 美元）。PetMed Express 的净利润率为-28.22%，股本回报率为-40.26%。该公司在本季度的收入为 4436 万美元。整体来看，研究分析师预计 PetMed Express 在当前财年将发布 0.19 美元的每股收益。</p>
<h2>机构投资者对 PetMed Express 的看法</h2>
<ul>
<li>这里有一只不在困境中的宠物股票</li>
</ul>
<p>几家对冲基金最近对该公司的持仓进行了调整。R Squared Ltd 在第二季度新建了约 34,000 美元的 PetMed Express 持仓。Occudo Quantitative Strategies LP 在第二季度以 51,000 美元的价格收购了 PetMed Express 的新股份。Oxford Asset Management LLP 在第二季度以 55,000 美元的价格收购了 PetMed Express 的新股份。CIBC Private Wealth Group LLC 在第三季度以 75,000 美元的价格购买了 PetMed Express 的新股份。最后，Bridgeway Capital Management LLC 在第二季度将其在 PetMed Express 的持股增加了 96.2%。Bridgeway Capital Management LLC 目前拥有 40,800 股该公司的股票，价值 135,000 美元，此前在上个季度又购买了 20,000 股。机构投资者和对冲基金持有该公司 73.33% 的股份。</p>
<h2>分析师评级变动</h2>
<p>几位分析师最近对 PETS 股票发布了报告。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 PetMed Express 股票的 “卖出（d）” 评级。Zacks Research 在 9 月 29 日的研究报告中将 PetMed Express 的评级从 “强烈卖出” 上调至 “持有”。最后，Wall Street Zen 在 10 月 18 日的研究报告中将 PetMed Express 的评级从 “持有” 下调至 “卖出”。一位研究分析师对该股票给予了 “持有” 评级，另外两位分析师给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “卖出”，平均目标价为 3.20 美元。</p>
<ul>
<li>这五只宠物护理股票中的一只可能成为下一个空头挤压</li>
</ul>
<p><strong>获取我们关于 PetMed Express 的最新研究报告</strong></p>
<h2>关于 PetMed Express</h2>
<p>（获取免费报告）</p>
<p>PetMed Express, Inc.以 1-800-PetMeds 品牌名义运营，作为一家在线和目录基础的宠物药房和零售供应商。该公司直接向消费者分发处方和非处方药物、营养补充剂、跳蚤和蜱虫控制产品以及一系列宠物健康用品。通过其位于佛罗里达州德尔雷海滩的持牌兽医药房，PetMed Express 为狗、猫和其他伴侣动物处理订单，提供品牌和仿制产品以及自有品牌的配方。</p>
<p>PetMed Express 于 1996 年由 Marc Puleo 创立，基于为寻求可靠兽医药物的宠物主人提供便利和节省成本的理念建立了其业务。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过 PetMed Express</li>
<li>华尔街选股者评选 2026 年第一股票</li>
<li>“6.6 万亿美元的客户银行存款面临风险”</li>
<li>华盛顿为战争做准备</li>
<li>崩盘前一个月</li>
<li>麦当劳的秘密</li>
</ul>
<p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 PetMed Express 吗？</h2>
<p>在你考虑 PetMed Express 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而 PetMed Express 并不在名单上。</p>
<p>虽然 PetMed Express 目前在分析师中被评为 “卖出”，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

PETS

<p>PetMed Express, Inc.（纳斯达克代码：PETS）在 12 月份的空头头寸显著增加了 68.2%，总计达到 2,698,921 股。该公司约有 12.9% 的股票被卖空，覆盖天数比率为 0.2 天。该股票最近下跌了 2.3%，市值为 7415 万美元。分析师对该股票的共识评级为 “卖出”，机构投资者持有 73.33% 的股份。公司报告上个季度的每股收益为负值（$0.41），低于预期$0.45</p>

<p>PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 2,698,921 shares, an increase of 68.2% from the November 30th total of 1,604,421 shares. Based on an average daily trading volume, of 12,363,353 shares, the short-interest ratio is presently 0.2 days. Approximately 12.9% of the shares of the stock are short sold. Approximately 12.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 12,363,353 shares, the short-interest ratio is presently 0.2 days.</p>
<div class="lb-trans"><p>PetMed Express, Inc.（纳斯达克代码：PETS - 获取免费报告）在 12 月份的空头头寸大幅增加。截至 12 月 15 日，空头头寸总计为 2,698,921 股，比 11 月 30 日的 1,604,421 股增加了 68.2%。根据平均每日交易量 12,363,353 股，目前的空头头寸比率为 0.2 天。大约 12.9% 的股票被做空。</p>
</div><p>Get <strong>PetMed Express</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>PetMed Express</strong> 警报：</p>
</div><h2>PetMed Express Trading Down 2.3%</h2>
<div class="lb-trans"><h2>PetMed Express 股价下跌 2.3%</h2>
</div><ul>
<li>Is Petco Health &amp; Wellness Out of the Doghouse on an EPS beat?</li>
</ul>
<div class="lb-trans"><ul>
<li>Petco Health &amp; Wellness 是否因每股收益超预期而摆脱困境？</li>
</ul>
</div><p>Shares of PetMed Express stock traded down $0.08 during trading hours on Friday, hitting $3.47. 108,088 shares of the company were exchanged, compared to its average volume of 7,696,855. The stock has a market capitalization of $74.15 million, a price-to-earnings ratio of -1.31 and a beta of 0.75. The business has a 50-day moving average of $2.46 and a 200-day moving average of $2.86. PetMed Express has a 1 year low of $1.57 and a 1 year high of $5.58.</p>
<div class="lb-trans"><p>在周五的交易时段，PetMed Express 股票下跌了 0.08 美元，报 3.47 美元。该公司交易了 108,088 股，较其平均交易量 7,696,855 股有所减少。该股票的市值为 7415 万美元，市盈率为-1.31，贝塔值为 0.75。该公司的 50 日移动平均线为 2.46 美元，200 日移动平均线为 2.86 美元。PetMed Express 的 1 年最低价为 1.57 美元，1 年最高价为 5.58 美元。</p>
</div><p>PetMed Express (NASDAQ:PETS - Get Free Report) last announced its quarterly earnings data on Friday, December 19th. The company reported ($0.41) EPS for the quarter, missing the consensus estimate of $0.04 by ($0.45). PetMed Express had a negative net margin of 28.22% and a negative return on equity of 40.26%. The company had revenue of $44.36 million during the quarter. As a group, research analysts anticipate that PetMed Express will post 0.19 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>PetMed Express（纳斯达克代码：PETS - 获取免费报告）最后一次公布季度财报是在 12 月 19 日（星期五）。该公司报告季度每股收益为（0.41 美元），低于市场共识预期的 0.04 美元，差距为（0.45 美元）。PetMed Express 的净利润率为-28.22%，股本回报率为-40.26%。该公司在本季度的收入为 4436 万美元。整体来看，研究分析师预计 PetMed Express 在当前财年将发布 0.19 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On PetMed Express</h2>
<div class="lb-trans"><h2>机构投资者对 PetMed Express 的看法</h2>
</div><ul>
<li>Here’s The One Pet Stock That’s Not in the Doghouse</li>
</ul>
<div class="lb-trans"><ul>
<li>这里有一只不在困境中的宠物股票</li>
</ul>
</div><p>Several hedge funds have recently made changes to their positions in the business. R Squared Ltd acquired a new position in PetMed Express during the 2nd quarter worth approximately $34,000. Occudo Quantitative Strategies LP acquired a new stake in PetMed Express during the 2nd quarter valued at $51,000. Oxford Asset Management LLP acquired a new stake in PetMed Express during the 2nd quarter valued at $55,000. CIBC Private Wealth Group LLC purchased a new stake in PetMed Express during the 3rd quarter worth $75,000. Finally, Bridgeway Capital Management LLC lifted its holdings in PetMed Express by 96.2% in the 2nd quarter. Bridgeway Capital Management LLC now owns 40,800 shares of the company's stock worth $135,000 after buying an additional 20,000 shares in the last quarter. Institutional investors and hedge funds own 73.33% of the company's stock.</p>
<div class="lb-trans"><p>几家对冲基金最近对该公司的持仓进行了调整。R Squared Ltd 在第二季度新建了约 34,000 美元的 PetMed Express 持仓。Occudo Quantitative Strategies LP 在第二季度以 51,000 美元的价格收购了 PetMed Express 的新股份。Oxford Asset Management LLP 在第二季度以 55,000 美元的价格收购了 PetMed Express 的新股份。CIBC Private Wealth Group LLC 在第三季度以 75,000 美元的价格购买了 PetMed Express 的新股份。最后，Bridgeway Capital Management LLC 在第二季度将其在 PetMed Express 的持股增加了 96.2%。Bridgeway Capital Management LLC 目前拥有 40,800 股该公司的股票，价值 135,000 美元，此前在上个季度又购买了 20,000 股。机构投资者和对冲基金持有该公司 73.33% 的股份。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Several analysts have recently issued reports on PETS shares. Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of PetMed Express in a research report on Wednesday, October 8th. Zacks Research upgraded PetMed Express from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Monday, September 29th. Finally, Wall Street Zen downgraded PetMed Express from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research report on Saturday, October 18th. One research analyst has rated the stock with a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of &#34;Sell&#34; and an average price target of $3.20.</p>
<div class="lb-trans"><p>几位分析师最近对 PETS 股票发布了报告。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 PetMed Express 股票的 “卖出（d）” 评级。Zacks Research 在 9 月 29 日的研究报告中将 PetMed Express 的评级从 “强烈卖出” 上调至 “持有”。最后，Wall Street Zen 在 10 月 18 日的研究报告中将 PetMed Express 的评级从 “持有” 下调至 “卖出”。一位研究分析师对该股票给予了 “持有” 评级，另外两位分析师给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “卖出”，平均目标价为 3.20 美元。</p>
</div><ul>
<li>One of these 5 Pet Care Stocks Can Be the Next Short Squeeze</li>
</ul>
<div class="lb-trans"><ul>
<li>这五只宠物护理股票中的一只可能成为下一个空头挤压</li>
</ul>
</div><p><strong>Get Our Latest Research Report on PetMed Express</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 PetMed Express 的最新研究报告</strong></p>
</div><h2>About PetMed Express</h2>
<div class="lb-trans"><h2>关于 PetMed Express</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>PetMed Express, Inc operates as an online and catalog-based pet pharmacy and retail supplier under the 1-800-PetMeds brand name. The company distributes prescription and non‐prescription medications, nutritional supplements, flea and tick control products, and a range of pet health supplies directly to consumers. Through its licensed veterinary pharmacy in Delray Beach, Florida, PetMed Express fills orders for dogs, cats and other companion animals, offering both branded and generic products alongside its own private‐label formulations.</p>
<div class="lb-trans"><p>PetMed Express, Inc.以 1-800-PetMeds 品牌名义运营，作为一家在线和目录基础的宠物药房和零售供应商。该公司直接向消费者分发处方和非处方药物、营养补充剂、跳蚤和蜱虫控制产品以及一系列宠物健康用品。通过其位于佛罗里达州德尔雷海滩的持牌兽医药房，PetMed Express 为狗、猫和其他伴侣动物处理订单，提供品牌和仿制产品以及自有品牌的配方。</p>
</div><p>Founded in 1996 by Marc Puleo, PetMed Express built its business on the premise of convenience and cost savings for pet owners seeking reliable access to veterinary medications.</p>
<div class="lb-trans"><p>PetMed Express 于 1996 年由 Marc Puleo 创立，基于为寻求可靠兽医药物的宠物主人提供便利和节省成本的理念建立了其业务。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than PetMed Express</li>
<li>Wall Street Stockpicker Names #1 Stock of 2026</li>
<li>“$6.6 Trillion Of Customer Bank Deposits At Risk”</li>
<li>Washington prepares for war</li>
<li>A month before the crash</li>
<li>The McDonald's Secret</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 PetMed Express</li>
<li>华尔街选股者评选 2026 年第一股票</li>
<li>“6.6 万亿美元的客户银行存款面临风险”</li>
<li>华盛顿为战争做准备</li>
<li>崩盘前一个月</li>
<li>麦当劳的秘密</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻警报由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in PetMed Express Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 PetMed Express 吗？</h2>
</div><p>Before you consider PetMed Express, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 PetMed Express 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PetMed Express wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而 PetMed Express 并不在名单上。</p>
</div><p>While PetMed Express currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 PetMed Express 目前在分析师中被评为 “卖出”，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

PetMed Express, Inc. (NASDAQ:PETS) 的空头头寸更新